Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Modeling household dynamics on Respiratory Syncytial Virus (RSV)

Respiratory Syncytial Virus (RSV) is the most common cause of respiratory tract infection in infants and children and shows increasing trend among elderly people worldwide. In many developing country settings, population and household structures have gone through some significant changes in the past...

Detaylı Bibliyografya
Asıl Yazarlar:	Mahikul, W, White, L, Poovorawan, K, Soonthornworasiri, N, Sukontamarn, P, Chanthavilay, P, F Medley, G, Pan-Ngum, W
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Public Library of Science 2019

Benzer Materyaller

Modeling household dynamics on Respiratory Syncytial Virus (RSV).
Yazar:: Wiriya Mahikul, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis
Yazar:: Mahikul, W, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

A population dynamic model to assess the diabetes screening and reporting programs and project the burden of undiagnosed diabetes in Thailand
Yazar:: Mahikul, W, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis.
Yazar:: Wiriya Mahikul, ve diğerleri
Baskı/Yayın Bilgisi: (2019-05-01)

Pathobiology of Respiratory Syncytial Virus (RSV)
Yazar:: Ralph A. Tripp, ve diğerleri
Baskı/Yayın Bilgisi: (2020-07-01)

Respiratory Syncytial Virus (RSV) Update
Yazar:: Leonard R. Krilov, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
Yazar:: Kinyanjui, T, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England and Wales and Finland: seasonality and cross-protection.
Yazar:: White, L, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication
Yazar:: Jackelyn Murray, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

The transmission dynamics of groups A and B human respiratory syncytial virus (hRSV) in England & Wales and Finland: seasonality and cross-protection
Yazar:: White, L, ve diğerleri
Baskı/Yayın Bilgisi: (2005)

Prevention and Treatment Strategies for Respiratory Syncytial Virus (RSV)
Yazar:: Dvir Gatt, ve diğerleri
Baskı/Yayın Bilgisi: (2023-01-01)

Predicting the relative impacts of maternal and neonatal respiratory syncytial virus (RSV) vaccine target product profiles: A consensus modelling approach.
Yazar:: Pan-Ngum, W, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Model evaluation of target product profiles of an infant vaccine against respiratory syncytial virus (RSV) in a developed country setting
Yazar:: Timothy Kinyanjui, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

The Development of Animal Models for Respiratory Syncytial Virus (RSV) Infection and Enhanced RSV Disease
Yazar:: Gengxin Zhang, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

Epidemiological changes of respiratory syncytial virus (RSV) infections in Israel.
Yazar:: Shira Hirsh, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Polymyalgia rheumatica following respiratory syncytial virus (RSV) vaccination
Yazar:: Mohamad El Labban, ve diğerleri
Baskı/Yayın Bilgisi: (2024-06-01)

Perinatal Lamb Model of Respiratory Syncytial Virus (RSV) Infection
Yazar:: Mark R. Ackermann, ve diğerleri
Baskı/Yayın Bilgisi: (2012-10-01)

Reducing respiratory syncytial virus (RSV) hospitalization in a lower-income country by vaccinating mothers-to-be and their households
Yazar:: Samuel PC Brand, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

Effects of formalin-inactivated respiratory syncytial virus (FI-RSV) in the perinatal lamb model of RSV.
Yazar:: Rachel J Derscheid, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Antibody gene transfer for prophylaxis of respiratory syncytial virus (RSV) infection
Yazar:: Antepowicz, A, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Monoterpene-Containing Substituted Coumarins as Inhibitors of Respiratory Syncytial Virus (RSV) Replication
Yazar:: Tatyana M. Khomenko, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
Yazar:: Selir M. Straliotto, ve diğerleri
Baskı/Yayın Bilgisi: (1994-03-01)

Respiratory syncytial virus (RSV) bronchiolitis: comparative study of RSV groups A and B infected children
Yazar:: Selir M. Straliotto, ve diğerleri
Baskı/Yayın Bilgisi: (1994-03-01)

Effects of palivizumab prophylaxis on respiratory syncytial virus (RSV) infections in Montenegro
Yazar:: Envera Lekic, ve diğerleri
Baskı/Yayın Bilgisi: (2024-05-01)

COVID-19 Lesson for Respiratory Syncytial Virus (RSV): Hygiene Works
Yazar:: Andrea Gastaldi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-12-01)

Immune Prophylaxis Targeting the Respiratory Syncytial Virus (RSV) G Protein
Yazar:: Harrison C. Bergeron, ve diğerleri
Baskı/Yayın Bilgisi: (2023-04-01)

Anti-RSV Peptide-Loaded Liposomes for the Inhibition of Respiratory Syncytial Virus
Yazar:: Sameer Joshi, ve diğerleri
Baskı/Yayın Bilgisi: (2018-05-01)

Defining the timing of respiratory syncytial virus (RSV) outbreaks: an epidemiological study
Yazar:: Enders Martin, ve diğerleri
Baskı/Yayın Bilgisi: (2005-03-01)

Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
Yazar:: Anne M Hause, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Model-based estimates of transmission of respiratory syncytial virus within households
Yazar:: Ivy K. Kombe, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

Correction: Sequence variability of the respiratory syncytial virus (RSV) fusion gene among contemporary and historical genotypes of RSV/A and RSV/B.
Yazar:: Anne M Hause, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Modelling the household-level impact of a maternal respiratory syncytial virus (RSV) vaccine in a high-income setting
Yazar:: Patricia T. Campbell, ve diğerleri
Baskı/Yayın Bilgisi: (2020-11-01)

New Inhibitors of Respiratory Syncytial Virus (RSV) Replication Based on Monoterpene-Substituted Arylcoumarins
Yazar:: Tatyana M. Khomenko, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Priorities for developing respiratory syncytial virus (RSV) vaccines in different target populations
Yazar:: Drysdale, S, ve diğerleri
Baskı/Yayın Bilgisi: (2020)

Impact of Respiratory Syncytial Virus (RSV) in Adults 60 Years and Older in Spain
Yazar:: Sara Jimeno Ruiz, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review
Yazar:: Anahita Poshtiban, ve diğerleri
Baskı/Yayın Bilgisi: (2024-08-01)

Pricey or priceless: cost-effectiveness of respiratory syncytial virus (RSV) prevention in infants
Yazar:: Xiao Li, ve diğerleri
Baskı/Yayın Bilgisi: (2024-01-01)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
Yazar:: Asunci&oacute;n Mej&iacute;as, ve diğerleri
Baskı/Yayın Bilgisi: (2008-09-01)

Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
Yazar:: O'Hagan S, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.
Yazar:: H K Brand, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)